GOSSAMERBIO Trademark

Trademark Overview

On Tuesday, April 16, 2019, a trademark application was filed for GOSSAMERBIO with the United States Patent and Trademark Office. The USPTO has given the GOSSAMERBIO trademark a serial number of 88387758. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 17, 2023. This trademark is owned by Gossamer Bio, Inc.. The GOSSAMERBIO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of allergies, asthma, autoimmune diseases and disorders, gastroenterology diseases and disorders, neurological diseases and disorders, oncology diseases and disorders, pulmonology diseases and disorders, fibrotic diseases and disorders and vascular diseases and disorders

Medical and pharmaceutical research services; pharmaceutical research and development
gossamerbio

General Information

Serial Number88387758
Word MarkGOSSAMERBIO
Filing DateTuesday, April 16, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 17, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 21, 2020

Trademark Statements

Description of MarkThe mark consists of a blue multi-circular design with the word "GOSSAMERBIO" centered in front of the circular design, with the word "GOSSAMER" in grey and the word "BIO" in blue. The color white represents the background and transparent areas and is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical preparations for the treatment of allergies, asthma, autoimmune diseases and disorders, gastroenterology diseases and disorders, neurological diseases and disorders, oncology diseases and disorders, pulmonology diseases and disorders, fibrotic diseases and disorders and vascular diseases and disorders
Pseudo MarkGOSSAMER BIO
Indication of Colors claimedThe color(s) blue and grey is/are claimed as a feature of the mark.
Goods and ServicesMedical and pharmaceutical research services; pharmaceutical research and development

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 2, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 2, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGossamer Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameGossamer Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Thursday, May 2, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 19, 2019NEW APPLICATION ENTERED
Tuesday, June 25, 2019ASSIGNED TO EXAMINER
Friday, May 3, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, July 1, 2019NON-FINAL ACTION WRITTEN
Monday, July 1, 2019NON-FINAL ACTION E-MAILED
Monday, July 1, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 11, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 12, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 11, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 13, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, December 13, 2019EXAMINERS AMENDMENT -WRITTEN
Friday, December 13, 2019EXAMINERS AMENDMENT E-MAILED
Friday, December 13, 2019EXAMINER'S AMENDMENT ENTERED
Monday, December 16, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 18, 2019ASSIGNED TO LIE
Wednesday, January 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 21, 2020PUBLISHED FOR OPPOSITION
Tuesday, January 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 17, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, September 9, 2020SOU EXTENSION 1 GRANTED
Wednesday, September 9, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, September 9, 2020SOU EXTENSION 1 FILED
Friday, September 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, February 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 14, 2022SOU TEAS EXTENSION RECEIVED
Thursday, February 4, 2021SOU TEAS EXTENSION RECEIVED
Thursday, February 4, 2021SOU EXTENSION 2 FILED
Thursday, February 4, 2021SOU EXTENSION 2 GRANTED
Wednesday, June 2, 2021ASSIGNED TO EXAMINER
Wednesday, September 1, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, September 1, 2021SOU EXTENSION 3 FILED
Wednesday, September 1, 2021SOU EXTENSION 3 GRANTED
Friday, September 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 14, 2022SOU EXTENSION 4 FILED
Monday, February 14, 2022SOU EXTENSION 4 GRANTED
Wednesday, February 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 30, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, August 30, 2022SOU EXTENSION 5 FILED
Friday, September 9, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 9, 2022SOU EXTENSION 5 GRANTED
Friday, February 3, 2023ASSIGNED TO EXAMINER
Monday, April 17, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, September 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 8, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, April 17, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

gossamerbio disorders diseases pharmaceutical research fibrotic medical development services pulmonology vascular